Cervical cancer
Research published years ago in the Cancer Journal found that not only are black women more likely to die of cervical cancer than women of other races, but they are also 77 percent more likely to die from it than experts previously thought. Prior estimates said 5.7 black women per 100,000 would die of the disease, but this new research puts the number at 10.1 per 100,000.
“Unlike breast cancer, cervical cancer is absolutely preventable in this day and age,” Dr. Phillips says. “In 2024, no woman should be diagnosed with cervical cancer.”
That’s partly because the HPV (human papillomavirus) vaccine is excellent at preventing infection of certain strains of human papillomavirus that can go on to cause cancer. But as of August 2016, only 6 out of 10 girls ages 13 to 17 and 5 of 10 boys in the same age range had started the vaccine series, which doctors recommend getting before age 26 for optimal results. Racial disparities are relevant here—a 2014 report from the CDC showed that around 71 percent of white girls 13 to 17 had completed the three-shot series, compared with about 62 percent of black girls in that age group. (The CDC changed these recommendations in 2016: It now says only two doses are necessary for optimal protection if the patient is between 11 and 12, but three are still ideal if the patient is between 15 and 26.)
Prevention, Treatment – Pap Smear and Early Care
Timely Pap smears are also wonderfully effective at preventing full-blown cervical cancer. “A Pap smear will detect preinvasive cervical cancer, but…studies have shown women who are having Pap smears may not get appropriate follow-up,” Dr. Phillips says. “A number of barriers exist for proper follow-up, and African-American women may be more vulnerable.”
Another potential factor, though, may be racial disparities in cervical cancer treatment. A 2014 study published in Plos One found that black women in Maryland were significantly less likely than white women to get surgery for cervical cancer instead of radiation or chemotherapy.
“Equivalent treatments are not being administered to white and black patients with cervical cancer in Maryland,” the study authors concluded. “Differences in care may contribute to racial disparities in outcomes for women with cervical cancer.”
A 2016 study in the Journal of Obstetrics and Gynecology reached a similar conclusion. The study looked at more than 16,000 patients who had received care for advanced cervical cancer, finding that white women received National Cancer Institute guideline-based care 58 percent of the time, black women 53 percent of the time, and Hispanic women 51.5 percent of the time.
Stay tuned for more..
